| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000014398 |
| Receipt No. | R000016549 |
| Official scientific title of the study | A Prospective, Multi-center Investigation of the performance of Endo GIA Reinforced Reload with Tri-Staple Technology in Gastrectomy for Gastric Cancer |
| Date of disclosure of the study information | 2014/06/27 |
| Last modified on | 2017/03/11 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | A Prospective, Multi-center Investigation of the performance of Endo GIA Reinforced Reload with Tri-Staple Technology in Gastrectomy for Gastric Cancer | |
| Title of the study (Brief title) | A Prospective, Multi-center Investigation of the performance of Endo GIA Reinforced Reload with Tri-Staple Technology in Gastrectomy for Gastric Cancer | |
| Region |
|
|
| Condition | ||
| Condition | Gastric Cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The objective of this study is to assess the performance of a surgical stapling device, Endo GIA Reinforced Reload with Tri-Staple Technology, used in gastrectomy. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Incidence of postoperative duodenal stump leakage |
| Key secondary outcomes | Staple line hemostasis, any staple malformation, incidence of serosal injury, any additional suturing, amount of blood loss, duration of surgery, incidence of intraoperative and postoperative adverse events, duration of drain placement, duration of hospital stay |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Patients with gastric cancer planned to undergo open or laparoscopic (distal or total) gastrectomy with Roux-en-Y reconstruction using a surgical stapling device
2)Patients aged 20 years or older 3)Patients with no history of upper abdominal surgery (with the exception of laparoscopic cholecystectomy) 4)Patients with an Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 or 1 5)Patients with adequate functions of major organs 6)Patients who have provided written informed consent in person for participation in the study |
|||
| Key exclusion criteria | 1)Women who are pregnant or possibly pregnant, or breastfeeding
2)Patients receiving continuous systemic (oral or intravenous) steroid therapy 3)Patients with concurrent diabetes mellitus with poor control (HbA1c > 8.0%) 4)Patients with a history of allergy to nickel or chrome (a contraindication in IFU) 5)Patients with concurrent mental disorder or psychiatric symptoms judged to preclude participation in this study 6)Other patients judged by the investigator to be inappropriate as a subject of this study |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Kazunari Misawa |
| Organization | Aichi Cancer Center Hospital |
| Division name | Department of Gastrointestinal Surgery |
| Address | 1-1 Kanokoden, Chikusa-ku, Nagoya-shi, Aichi Prefecture, 464- 8681 |
| TEL | 052-762-6111 |
| misawakzn@aichi-cc.jp | |
| Public contact | |
| Name of contact person | Kazunari Misawa |
| Organization | Aichi Cancer Center Hospital |
| Division name | Department of Gastrointestinal Surgery |
| Address | 1-1 Kanokoden, Chikusa-ku, Nagoya-shi, Aichi Prefecture, 464- 8681 |
| TEL | 052-762-6111 |
| Homepage URL | |
| misawakzn@aichi-cc.jp | |
| Sponsor | |
| Institute | Aichi Cancer Center Hospital, Department of Gastrointestinal Surgery |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Covidien Japan Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 愛知県がんセンター中央病院(愛知県)
神奈川県立がんセンター(神奈川県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Prospective, multi-center, single-arm, observational registry study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016549 |